Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology.
A HeLa T4+ cell line persistently infected with human immunodeficiency virus type 1 (HIV-1) was used in an indirect immunofluorescent antibody assay (IFA) system to explore its potential suitability as an alternative source of viral antigen for confirmatory IFA in HIV serology. In a study of 121 serum samples chosen because they were reactive on repeat examination by enzyme immunoassay but nonspecific by IFA by using HIV-1-infected H9 cells (H9 IFA) or gave discrepant results by enzyme immunoassay and H9 IFA, the specificity and sensitivity of the HeLa T4+ IFA were comparable to those of Western blot (immunoblot), and identification of the true positive samples among these discrepant or nonspecific samples by HeLa T4+ IFA was approximately twice that by H9 IFA. The primary advantages of using the HeLa cell line rather than lymphoid cell lines in IFA are that cells can be grown as a monolayer and that the individual cells are much larger. The cell membrane, cytoplasm, and nucleus are easily discernible; this allows specific and nonspecific staining to be distinguished. At least eight different nonspecific nuclear and cytoplasmic staining patterns were identified in this study by using T4+ cells.
Viral and Rickettsial Disease Laboratory, California State Department of Health Services, Berkeley 94704.
B
B
Forghani
J W
JW
Hurst
C S
CS
Chan
D005069:Evaluation Studies as Topic; D005455:Fluorescent Antibody Technique / Q000592:standards; D015483:HIV Antibodies / Q000032:analysis*; D015488:HIV Antigens; D015658:HIV Infections / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D006367:HeLa Cells; D006801:Humans
D015483:HIV Antibodies; D015488:HIV Antigens